Ophthalmology Therapeutics: Does current pipeline innovation hold the potential to affect the future ophthalmology market?

This Frontier Pharma: Ophthalmology Therapeutics assesses first-in-class innovation in the ophthalmology pipeline, highlighting key trends in the distribution of these products.

Pune, India - March 14, 2018 /MarketersMedia/ —

The pipeline is varied in terms of molecular targets and molecule types. Products acting on the immune system and neurotransmitter signaling are the most prevalent, but no single target dominates by any clear margin. There are a total of 194 first-in class pipeline products in development for ophthalmologic indications 38% of the 512 pipeline products for which there is a disclosed molecular target. Encompassing gene therapies, slowing of the visual cycle and antisense therapies, the pipeline appears robust and has huge potential to strengthen treatment options for ophthalmological disorders.

Access Report Details at: https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs

Reasons To Buy
• Understand the current clinical and commercial landscape. This includes a comprehensive study of disease pathogenesis, diagnosis and prognosis, and the treatment options available.
• Visualize the composition of the ophthalmological disorders market in terms of dominant molecule types and targets, and understand the current unmet needs and how they can be addressed. This knowledge allows a competitive understanding of gaps in the market.
• Analyze the ophthalmological disorders pipeline and stratify by stage of development, molecule type and molecular target. There are strong signs in the pipeline that the industry is seeking novel approaches to treating ophthalmological disorders to overcome the overwhelming level of unmet need.
• Assess the therapeutic potential of first-in-class targets. Using a proprietary matrix, first-in-class products have been assessed and ranked according to clinical potential. Promising early-stage targets have been reviewed in greater detail.
• Identify commercial opportunities in the ophthalmological disorders deals landscape by analyzing trends in licensing and co-development deals, and a curated list of ophthalmological disorder therapies that have not yet been involved in deals, and may offer potential investment opportunities.

Get this report at: https://www.themarketreports.com/report/buy-now/935550

In the past the ophthalmological disorders therapy area has suffered from a lack of full understanding of the pathophysiology and underlying mechanisms of the diseases. However, as this knowledge has improved vastly in recent years, potential targets have been identified for treatment. As well as the main disorders previously mentioned, there is also interest in developing treatments for indications such as allergic conjunctivitis and retinitis pigmentosa. The approval of a gene therapy for retinitis pigmentosa is indicative of this progress, and represents the first gene therapy approved for an inherited condition by the FDA.

Inquire for more details at: https://www.themarketreports.com/report/ask-your-query/935550

Contact Info:
Name: Shirish Gupta
Email: sales@themarketreports.com
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL: https://marketersmedia.com/ophthalmology-therapeutics-does-current-pipeline-innovation-hold-the-potential-to-affect-the-future-ophthalmology-market/314326

For more information, please visit https://www.themarketreports.com/report/frontier-pharma-ophthalmology-therapeutics-gene-therapies-and-first-in-class-targets-offer-novel-treatments-for-substantial-unmet-needs-in-a-pipeline-dominated-by-angiogenic-and-immune-signaling-drugs%20%20

Source: MarketersMedia

Release ID: 314326

More News From sports.morningdispatcher.com

Ex-soccer star says Iran officials barred him from program

Jun 23, 2018

TEHRAN, Iran — The former captain of Spain's national soccer team, Carles Puyol, is claiming that Iranian TV officials barred him from appearing as a World Cup commentator because of his long hair. Iranian officials have denied the claim. The Saturday report by Jam-e Jam newspaper's TV affiliate quotes government TV official Morteza Mirbagheri as saying the issue was about money not hair: "There is no need for a foreign figure to receive several hundred million (Iranian rials) for a few minutes on a sports program." Puyol was invited to appear on a special World Cup 20118 sport program Wednesday...

Kohli says he's fit to lead India on England tour

Jun 23, 2018

NEW DELHI — Virat Kohli has recovered from a neck injury and will lead India on the cricket tour of Ireland and England. Kohli had to cancel a contract with English county team Surrey for this month after he was injured while fielding in the Indian Premier League in mid-May. The injury hasn't been specified. He played the next IPL match then had to rest and recover. He faced a fitness test. "I'm 100 percent ready to go. Neck is fine," the captain said at a pre-tour news conference on Friday, the day before the team departs. "I have passed...

Turkey charges father of NBA's Kanter as terror group member

Jun 23, 2018

ISTANBUL — A Turkish court has accepted an indictment charging the father of NBA player Enes Kanter with "membership in a terror group," the country's official news agency reported Monday. The indictment followed an investigation of Mehmet Kanter, and prosecutors planned to seek his conviction and a prison term of five to 10 years at trial, Anadolu Agency said. It's unclear when the trial in western Tekirdag province would begin. Enes Kanter, who plays for the New York Knicks, is a follower of a U.S.-based Turkish cleric who the government accuses of masterminding a failed military coup in 2016. Cleric...

Afghanistan lose maiden test to India by innings in 2 days

Jun 23, 2018

BANGALORE, India — Afghanistan succumbed to top-ranked India by an innings and 262 runs inside two days of its maiden cricket test on Friday. India completed its first innings in the morning on 474 then bowled out the Afghans for 109 and 103 for its biggest win by innings. It was the fourth instance in test history of a team being bowled out twice in one day. Left-arm spinner Ravindra Jadeja took six wickets, including 4-17 in the second innings, and Ravichandran Ashwin claimed five, including 4-27 in the first. India stand-in skipper Ajinkya Rahane believed better days were ahead...

Afghanistan hits back after 2 centuries for India in test

Jun 23, 2018

BANGALORE, India — Afghanistan hit back with five wickets after Shikhar Dhawan and Murali Vijay scored centuries for India to finish day one of the one-off cricket test on 347-6 on Thursday. India was cruising at 280-1 after two rain delays when it suddenly lost Vijay and Lokesh Rahul in the space of three deliveries and five wickets in all in the last session. In its maiden test, Afghanistan's spinners struggled in the first two sessions while the seamers made the early breakthroughs before the spinners got their lengths right and took the last two wickets. India lost five wickets...

About Us

Get all the up-to-date breaking news about politics, business, entertainment, sports, lifestyles, weather, traffic, and local news in a seamless digital environment only in Morning Dispatcher.

Contact us: sales[at]morningdispatcher.com

Subscribe Now!

Quick Links

HomePress